AI assistant
Torrent Pharmaceuticals Ltd. — M&A Activity 2025
Sep 23, 2025
61979_rns_2025-09-23_7a2d6a21-fc7d-4e0d-b835-624ae908e701.pdf
M&A Activity
Open in viewerOpens in your device viewer
==> picture [95 x 30] intentionally omitted <==
23[rd] September, 2025
The Dy. General Manager (Listing Dept.) BSE Limited, Corporate Relationship Dept., 1[st] Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001 (BSE Scrip Code: 500420)
Mumbai – 400 051
(NSE Scrip Code: TORNTPHARM)
Dear Sir,
Sub: Disclosure under Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Further, to the Media Release titled "Torrent Pharma to acquire controlling stake in J. B. Chemicals & Pharmaceuticals from KKR” dated 29[th] June 2025 and Stock exchange intimation dated 3[rd] July, 2025, this is to inform you that the Competition Commission, South Africa has granted its approval for the transaction on 22[nd] September, 2025. We are committed to continue our relationships with all our customers on fair and consistent terms.
Thanking you,
Yours sincerely,
For TORRENT PHARMACEUTICALS LIMITED
CHINTAN Digitally signed by CHINTAN M TRIVEDI M TRIVEDI Date: 2025.09.23 20:37:14 +05'30'
CHINTAN M. TRIVEDI COMPANY SECRETARY
_________________ TORRENT PHARMACEUTICALS LIMITED
CIN: L24230GJ1972PLC002126
Reg.Office : Torrent House, Off Ashram Road, Ahmedabad- 380 009, India. Phone: +91 79 26599000, Fax: +91 79 26582100, www.torrentpharma.com, Email : [email protected]